Prellis Biologics
Prellis Biologics is a Berkeley, California biotechnology company that discovers fully human antibody therapeutics by combining wet-lab human immunology with machine learning. Its EXIS (Externalized Immune System) platform uses LNO lymph node organoids — 3D tissue printed with holographic two-photon photolithography — to recreate human lymph node biology in vitro, raise true human antibody responses across genetically diverse donors, and feed the resulting sequence and characterization data into generative AI models that predict and optimize candidates in an iterative lab loop. The company sells antibody discovery collaborations and licensed therapeutic programs to pharmaceutical partners rather than software, and publishes no public developer program, API, SDK, or machine-readable specification.
Prellis Biologics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Life Sciences, Antibody Discovery, and Drug Discovery.
Prellis Biologics’ developer surface includes engineering blog, support, and 6 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 1
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API